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Background: Considering malaria prevalence declines in parts of sub-Saharan Africa, such as Gabon, identification
of the human infectious reservoir is important for successful malaria control. Microscopic and sub-microscopic
parasites contribute to malaria transmission. The aim of the present study was to evaluate the proportion of
microscopic and sub-microscopic gametocyte carriers among febrile patients in two different areas of Gabon.
Methods: Samples from febrile children aged less than 11 years old were collected from February 2008 to January
2009 at two health centres of Gabon. Patients were screened for the presence of asexual Plasmodium falciparum
parasites. Gametocyte carriage was determined by microscopy and QT-NASBA.
Results: Gametocytes were detected in 5.3% (n = 16/304) of children by microscopy compared to 45.7% (n = 139/
304) by QT-Nasba. Sub-microscopic gametocyte carriage (ie microscopy negative and QT-Nasba positive) was found
in 89.2% (n = 124/139) of patients. Among patients with microscopically detected trophozoites, the proportion of
sub-microscopic gametocyte (SMG) carriers was 58.4% (n = 118/202) and 6% in samples from children with
negative slides (p < 0.01). In Oyem, where malaria prevalence is three-fold higher than in Owendo, SMG carriage
was more frequent (49.0% vs 32.6% in Owendo; p < 0.01).
Conclusion: Sub-microscopic gametocytaemia is common among Gabonese febrile children. They might strongly
contribute to maintain malaria transmission. However, further analysis of sub-microscopic parasite carriage among
asymptomatic individuals will be helpful to better characterize malaria transmission.
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A trend towards a decrease of malaria prevalence was
noticed in many malaria endemic areas of sub-Saharan
Africa [1-5]. To maintain malaria control and elimin-
ation efforts, targeting gametocytes, either alone or as
part of integrated control programmes, is essential [6,7].
Indeed, microscopic and sub-microscopic gametocytes
sustain malaria transmission. Their presence in human
peripheral blood and their infectiousness determine the
success of transmission from human to mosquitoes [8-10].
It is assumed that a little proportion of patients with a pri-
mary infection develop patent gametocytaemia, a good
indicator to characterize the level of transmission in* Correspondence: dpmawili@hotmail.com
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distribution, and reproduction in any mediumendemic areas [11]. However, sexual and asexual sub-
microscopic infection carriers are frequent and constitute
an important parasite reservoir, mainly among asymptom-
atic and target population even after treatment [11-13].
They are barriers to interrupt malaria transmission and to
the successful of malaria elimination. Therefore, the import-
ance of the prevalence of gametocyte carriers as human
infectious reservoir needs to be investigated. A good anti-
malarial drug must have a high gametocytocidal activity.
However recent data suggest that submicroscopic gameto-
cytes carriage could persist after anti-malarial treatment
[14,15]. This duration of gametocytaemia is increased in
case of drug resistant parasite carriage and maintains the
spread of drug resistance [16,17]. Therefore, the presence of
submicroscopic gametocytes following anti-malarial treat-
ment could be a possible marker of resistant parasites, anded Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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using molecular methods.
Compared to microscopy, molecular techniques were
developed and applied with good results for Plasmodium
falciparum asexual and sexual forms detection [18,19].
The Quantitative Nucleic Acid Based-Amplification (QT-
NASBA) has been reported to be a highly sensitive mo-
lecular method for sub-microscopic gametocytes detection
and quantification [18]. The use of QT-Nasba revealed
that individuals living in malaria endemic areas may carry
sub-microscopic gametocytes that can lead to Anopheles
infection [20,21].
In Gabon, a change was observed in malaria epidemi-
ology and in the profile of the target population. A de-
crease of malaria prevalence was observed between 2005
and 2008 followed by a rebound in 2011 [22,23]. Never-
theless, few data on malaria transmission are available
since the implementation of artemisinin-based combination
therapy (ACT) in Gabon. Likewise, data on gametocyte car-
riage are scarce. In the present study, the proportion of
microscopic and sub-microscopic gametocytes (SMG) car-
riers was evaluated among febrile patients in two areas of
Gabon with different level of malaria prevalence.
Methods
Study areas
The study was conducted in Gabon where malaria trans-
mission is perennial and predominantly due to P. falcip-
arum. From February 2008 to January 2009, recruitment
was carried out at the Centre Hospitalier Régional d’Oyem
(CHRO) and the Centre de Santé Communautaire
d’Owendo (CSCO), 25 km south of Libreville, the capital
city of Gabon [24]. Malaria prevalence among febrile chil-
dren was 39% and 11% in Oyem and Owendo, respectively.
Sample collection
This study was a part of a health facility-based project initi-
ated by the National Malaria Control Programme (NMCP),
which aimed to evaluate malaria prevalence and to per-
form molecular analysis of P. falciparum isolates. Children
under 11 years of age, presenting at hospital for a consult-
ation with fever (axillary temperature ≥ 37.5°C) or a history
of fever in the preceding 48 h, were enrolled from February
2008 to January 2009. Body temperature, history of fever
and sex were collected from each patient. During this pro-
spective study that lasted one year, a single blood sample
was taken from each febrile patient included, for malaria
diagnosis. Fifty microlitres of blood were spread on filter
papers for molecular testing that include analysis of genetic
diversity, drug resistance markers and SMG detection. Fil-
ter papers were dried and stored in individual plastic bags
at room temperature (20-25°C) until processed. A random
subset of approximately 16 samples with microscopic P.
falciparum infection and eight negative samples wereselected per month by personal blinded to all information
concerning the patients and the microscopic results.
Malaria diagnosis
Malaria diagnosis was performed according to the method
of Lambarene, as detailed elsewhere [25]. Briefly, 10 μL of
blood is distributed on a 10- by 18-mm area of a micro-
scope slide, which is dried and stained by a 20% Giemsa
solution. Experienced microscopists read the smears
using a light microscope with the 100× objective under
oil immersion (×1,000 magnification). Parasitaemia was
expressed as a number of parasites per microlitre of
blood. Parasites stages (microscopic asexual forms and
gametocytes) density was determined. Parasite species
was identified in the matched thin blood smears. Smears
were considered as negative if the examination of 100
oil immersion fields did not reveal any parasites. They
were classified as positive in case of a positive blood smear
(PBS), irrespective of the parasite density, and as negative
when microscopic examination was negative. Patients with
a positive blood smears with a non-falciparum species
were not selected.
Gametocyte detection: nucleic acid extraction and Pfs25
mRNA real-time QT-NASBA
Nucleic acids were extracted from blood collected on fil-
ter paper with the guanidiumisothiocyanate (GuSCN)/
silica procedure using semi-automated analyzer Mini-Mag
(Biomérieux®). Pfs25 mRNA QT-NASBA was performed
as previously described [8]. Briefly, real-time QT-NASBA
for Pfs25 mRNA was done on a Nuclisens EasyQ analyser
(Biomérieux®, France). The Nuclisens Basic Kit served for
amplification according to the manufacturer’s instructions
at a KCl concentration of 80 mmol/L with specific pri-
mers. For Pfs25 mRNA, the forward primer was: 5’-gac tgt
aaa taa acc atg tgg aga-3’; the reverse primer was: 5’-aat
tct aat acg act cac tat agg gag aag gca ttt acc gtt acc aca
agt ta-3’. Pfs25 molecular beacon was 5’-TexasRed-cga tcg
ccg ttt cat acg ctt gta acg atc g-DABSYL-3’.
Each reaction was performed in a total volume of
10 μL. For gametocyte detection, a culture of 3D7 P. fal-
ciparum mature gametocytes, with a parasitaemia of
0.35%, was used in duplicate during each experiment as
positive control. Samples were also analysed in duplicate
and considered positive when the time-point of amplifica-
tion at which the fluorescence detecting target amplicons
(time to positivity = TTP) exceeded the mean fluorescence
of three negative controls plus 20 standard deviation (SD).
Ethical aspects
This study was a part of a project designed by the MNCP
for morbidity and diagnostic tools evaluation in Gabon.
Molecular analysis for gametocyte detection and drug re-
sistance was part of this project. Gabonese Ministry of
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ents or guardians were informed about the study protocol,
either for the comparison of diagnostic tools or for the
consecutive molecular analysis. Their oral consent was re-
quired prior to enrolment.
Sample size estimation
Sample size was calculated by considering i) the previous
data estimating that 10% of febrile children have micro-
scopic gametocytaemia [26]; ii) the prevalence of game-
tocytes detected by PfS25 being at least twice of that
detected by microscopy in clinic patients [11], iii) at least
60% of ill patients with only microscopic asexual forms
can have sub-microscopic gametocytaemia [9,27]. Sam-
ple size calculation was done using STATA software and
Epi-Info 6 with a risk of 5% and accuracy of 10%. Therefore,
a minimum number of 60 samples per site was estimated.
However, considering that in perennial transmission areas,
10 to 30% of febrile children have sub-microscopic P. fal-
ciparum infections additional microscopically negative sam-
ples were collected (30%). A minimum of 60 dried blood
spot from patients with positive blood smears and 30 sam-
ples from individuals microscopically negative was then
required.
Data analysis
Data were entered using Epi info version 2000 and were
analysed with Stata 9.2 (Stata Corporation, College Station,
TX USA). SMG carriers were defined as indiduals harbour-
ing gametocytes exclusively detected with Nasba. Continu-
ous variables are presented as medians [25th and 75th
percentiles]. Differences between groups were assessed
using chi-squared or Fisher’s exact tests for proportions.
Continuous variables were compared using the student t-
test, Mann Whitney U-test or Kruskal-Wallis test as appro-
priate. Spearman’s test was used to assess the correlationTable 1 Characteristics of the study population
All
n = 304
Age, median [IQR], months 36[21-72]
T°, median [IQR], C 38[37.1-39.1
Malaria infection
Microscopy
MPBS** (trophozoïtes), n (%) 202 (66.4)
Trophozoïtes density, median [IQR] P/μL 26110[3024-111860]
MPBS* (gametocytes) n (%) 16 (5.3)
Gametocytes density, median [IQR] P/μL 119[23-875]
Nasba
Gametocytes n (%) 139 (45.7)
SMG*** n (%) 124 (40.7)
*for comparison between Oyem and Owendo; MPBS**: malaria positive blood smeabetween continuous variables. A p-value of less than 0.05
was considered significant.
Results
Samples from 304 children were analysed. Half of them
(n = 153) were collected from patients living in Owendo.
The median age of the children was 36 [21-27] months;
those from Oyem were the youngest (Table 1); 54.9%
were male.
Microscopic P. falciparum sexual and asexual forms
A total of 202 (66.4%) samples from patients with posi-
tive blood smears were alternatively collected in the two
sites (p = 0.9). The median parasite density was 26,110
IQR [3,024-111,860] trophozoites/μl (Table 1). Gameto-
cytes were detected in 5.3% (n = 16) of sample samples
with asexual forms only. The median gametocytaemia
was of 119 IQR[23-875] gametocytes/μL. More than half
of the 16 microscopic gametocyte carriers (n = 11; 68.7%)
lived in Owendo (Table 1).
Plasmodium falciparum sub-microscopic
gametocytes carriers
Based on molecular analysis, 139 (45.7%) samples car-
ried gametocytes, of which 89.2% (n = 124/139) were
sub-microscopic. The presence of mature gametocytes
was confirmed by Pfs25 mRNA QT-NASBA in 15 of the
16 samples with gametocytes detected on blood smears.
The microscopic parasite density was greater than 100
gametocytes/μl, in 14 out of the 15 samples (Table 2).
Molecular detection was not successful in one sample
with 7 gametocytes/μl detected by microscopy.
The proportion of Pfs25 QT-Nasba gametocyte car-
riers was higher in Oyem (52.3%) compared to Owendo
(39.2%) (p < 0.02). A similar trend was observed for
sub-microscopic gametocytes carriage (ie negative bloodOyem (CHRO) Owendo (CSCO) p-value*
n = 151 n = 153
24[16-48] 48[24-84] < 0.01
38.5[37.5-39.5] 37.7[36.9-38.7] < 0.01
102 (67.5) 100 (65.3) 0.9
34480[3854-122675] 18008[2742-96600] 0.2
5 (3.3) 11 (7.2) 0.12
119[30-423] 1053[7-2100] 0.9
79 (52.3) 60 (39.2) 0.02
74 (49.0) 50 (32.6) < 0.01
rs; SMG***: sub-microscopic gametocytes.
Table 2 Proportion of gametocytes detected by Nasba
according to the presence of microscopic trophozoïtes
and gametocytes
Gametocytes detection (Nasba)
Detected Not detected Total
Microscopy
Trophozoites
-Positive slides, n (%) 133 (65.8) 69 (34.2) 202
-Negative slides, n (%) 6 (5.9) 96 (94.1) 102
Gametocytes
-Positive slides, n (%) 15 (93.7) 1 (6.3) 16
-Density (gametocytes/μl)
0 118 (40.9) 170 (59.1) 288
1-50 1 (50.0) 1 (50.0) 2
51-500 5 (100.0) 0 (0.0) 5
501-1000 5 (100.0) 0 (0.0) 5
> 1000 4 (100.0) 0 (0.0) 4
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significantly more frequent in Oyem (49.0%; n = 74/151
vs 32.7%; 50/153 in Owendo) (Table 1). The proportion
of gametocytes only detected by QT-Nasba was 58.4%
(n = 118) among patients with microscopically detected
trophozoites and 6% among those with negative slides
(p < 0.01).
Discussion
Data on gametocyte carriage in population from malaria
endemic areas are needed to estimate the infectious res-
ervoir and battle the ongoing transmission of malaria.
This is important in the light of renewed malaria elimin-
ation and eradication efforts [28].
QT-NASBA gametocytes detection is currently one of
the best methods to detect sub-microscopic gameto-
cytes. It is usually performed with mRNA extracted from
frozen blood sample pellets. Few authors reported game-
tocytes detection by using filter paper with Nasba tech-
nology [29-31]. Recently, RNA extraction from infected
red blood cells produced in culture, spotted on filter
paper was done and its analysis using QT-Nasba led to
good results [30,31]. In the present study, nucleic acids
were extracted from field P. falciparum isolates collected
on filter paper and stored at room temperature (20-25°C).
All, but one, samples detected positives by microscopy
were also positive with QT-NASBA. Therefore, RNA ex-
tracts analysis from non-frozen blood samples stored
under stable conditions give reliable results for determin-
ing gametocyte prevalence. The lack of amplification in
one sample could be due to several factors, such as the
gametocyte density (< 10/μl) or an unsuccessful RNA ex-
traction although a semi-automated analyzer was used.
Inclusion of a control to assess the extraction efficiencywould have been informative, but this is not currently
performed as reported in previous studies [8,20,32]. Never-
theless, the suitability of this approach in areas without
modern equipment has been confirmed with culture-
produced gametocytes, as well as field isolates collected on
filter paper [30,31].
In the present study, 5.3% of the febrile children screened
had microscopically detected gametocytes. Using molecular
detection, this proportion increased to 45.7%, whose 90%
were sub-microscopic gametocytes carriers. The higher rate
of gametocytes detected by QT-Nasba compared to micros-
copy (ranging from 15% to 91%) has been frequently re-
ported by other authors [9,32-34].
The results obtained here confirm the high frequency
of sub-microscopic gametocytes carriage among symptom-
atic patients harbouring microscopically detected asexual P.
falciparum forms (58.4%) as reported elsewhere [35]. This
proportion can reach 90% [33,34].
According to the study site, the profile of sub-
microscopic gametocytes carriage is the same as the
microscopic P. falciparum asexual form prevalence. Both,
sexual and asexual P. falciparum infections, are more fre-
quently observed in children living in Oyem (52.3% and
39%) compared to Owendo (39.2% and 11%) [24]. Okell et
al showed a relationship between malaria prevalence by
microscopy and PCR when they analysed 106 surveys
[13]. A survey performed three years later in Oyem and in
Libreville, located at 25Kms from Owendo, confirmed the
higher burden of malaria in the area of Oyem [23]. It
will be interesting to study the sub-microscopic malaria
prevalence in patients living in areas with a lower en-
demicity, such as Owendo. Indeed, a higher frequency
of sub-microscopic infection is often described in set-
tings where slide prevalence is below 24% [13].
All sub-microscopic gametocytes found in the present
study were detected in blood samples collected from febrile
children before any medical prescription. This finding is
important in the current context of malaria strategies con-
trol update in Gabon where a rebound of malaria preva-
lence is observed [23]. In fact, most of the anti-malarial
drugs have a limited activity against late stage of P. falcip-
arum gametocytes [14,35]. Although ACT shortens the
duration of post-treatment circulation of mature gameto-
cytes, a low density of mature sexual forms can persist after
apparently complete clearance of trophozoites [14,35]. On
day 28 after ACT treatment, a proportion of 12-40% of
cured patients was found to be still gametocytaemic; a
status which allows post-treatment malaria transmission
[9,14,36,37]. Therefore, it can be assumed that the rebound
of P. falciparum infections in Gabon between 2005 and
2008 could be partly explained by the importance of
the sub-microscopic infectious reservoir (above 40%)
that maintains a continuous transmission. Microscopic
or sub-microscopic gametocyte carriage contributes to
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sustainment [20]. Taken altogether, these observations
highlight the need of a treatment with gametocytocidal
drugs. Adding primaquine (PQ) to ACT is suggested to
enhance anti-malarial drugs impact on malaria transmis-
sion, although concerns about PQ treatment induced hae-
molysis in case of G6PD deficiency exist [38,39].
This study presents some limits. sub-microscopic ga-
metocytes carriage was only determined in symptomatic
children. Thus, it is probably underestimated when consid-
ering that asymptomatic microscopic and sub-microscopic
infections carriers are frequent in high but also low trans-
mission settings whatever the seasonality [13,40]. The sam-
ple selection did not allow an analysis of sub-microscopic
gametocytes prevalence according to the age. Gametocyte
viability and infectivity to mosquito were not evaluated. It
is however already known that sub-microscopic gameto-
cytes are responsible for 20-50% of transmission to mos-
quito [13,20].
Conclusion
Frequent sub-microscopic gametocytaemia among chil-
dren presenting at clinics is observed in areas of Gabon
with different malaria burden. They would constitute an
important reservoir of parasites, even in Owendo where
malaria prevalence tends to be low. Therefore, further stud-
ies analysing the sub-microscopic P. falciparum prevalence
including gametocytes carriage in asymptomatic children
and adults, the acquired immunity in different malaria in-
tensity areas and entomological data will be helpful to high-
light the characterization of the disease transmission in the
country.
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